YOKNEAM, Israel, March 16, 2021 /PRNewswire/ — InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has filed a complaint with the United States International Trade Commission (“ITC”) alleging ILOODA’s SecretRF fractional radio frequency (“RF”) microneedling system, distributed in the United States by Cutera, Inc., infringes U.S. Patent No. 10,799,285. Additionally, InMode requested that the ITC initiates an investigation into ILOODA’s infringing imports and issue an exclusion order to bar importation of SecretRF.
“As a disrupter in medical aesthetic devices, InMode has committed significant research and development resources to the development of its differentiated RF technologies,” InMode’s Chief Technology Officer, Dr. Michael Kreindel, commented. “Those efforts have led to an ever-expanding intellectual property (IP) portfolio, a fundamental component of InMode’s strategic plan to grow shareholder value. InMode will continue to develop efficacious minimally invasive and hands-free treatments using its patented technology and plans to vigorously defend its IP.”
Since its inception, InMode has worked tirelessly to develop state-of-the-art electro-surgical bi-polar radiofrequency devices, bringing breakthrough aesthetic and wellness procedures to the market for the face, body, and skin. Through its ongoing commitment to research and development, InMode has become an innovative leader and has pioneered full body fractional RF technology through the commercialization of the Morpheus8 Subdermal Adipose Remodeling (SARD) device.
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel RF technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode’s future financial or operating performance. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “would” and similar expressions that concern our expectations, strategy plans or intentions. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict, including with respect to the impact of the COVID-19 global outbreak. As a result, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 10, 2021, risk factors relating to the COVID-19 global outbreak and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.
Investor Relations Contact:
SOURCE InMode Ltd.
Company Codes: NASDAQ-NMS:INMD
New York Bone & Joint Specialists: New Invention Stops or Delays the Progression of Osteoarthritis of the Knee
Ping An AskBob Doctor’s Smart Imaging Model for Diagnosis of Pelvic and Hip Injuries is a Breakthrough for Artificial Intelligence
April 1, 2021
Ping An Insurance (Group) Company of China, Ltd. “Ping An” announced that Ping An AskBob Doctor’s smart imaging model for diagnosing pelvic and hip injuries is the first of its kind to accurately detect all kinds of trauma-related findings simultaneously in X-ray images.
In a research paper published in the international journal Nature Communications, the model is shown to overcome the limitation of other artificial intelligence (AI) systems, which can only detect individual fractures.
The model, a deep learning algorithm, can help physicians make faster, more accurate diagnoses and save lives. Hip fractures mainly occur in elderly people and patients with major trauma. Although they are not directly fatal, complications can lead to a high mortality rate. Reducing the rate of missed diagnoses, improving the comprehensiveness of the detection, and providing accurate diagnoses is critical.
Ping An Health Technology Research Institute, Ping An Smart City, Ping An Good Doctor and the Department of Trauma and Emergency Surgery of Chang Gung Memorial Hospital in Taiwan jointly released the research paper “A scalable physician-level deep learning algorithm detects universal trauma on pelvic radiographs”. The research team gathered the pelvic X-ray data of 1,888 emergency room patients to evaluate the model’s performance in obtain the fracture results and locations. It achieved an overall accuracy of 92.4%. Compared with general clinical diagnoses, the model substantially improves detection accuracy, speeds up the treatment progress, improves the treatment effectiveness on high-risk patients, and reduces the economic cost to patients through earlier detection and treatment.
This is the first AI algorithm to detect all fracture types captured on the X-ray images, including, but not limited to, hip fractures, pelvic fractures, femoral fractures, hip dislocation and artificial joint peripheral fractures.
As of March, 2021, the AskBob Doctor AI pelvic trauma detection technology has been used in the real-life clinical environment in Chang Gung Memorial Hospital in Taiwan for nearly eight months. The results have shown that the misdiagnosis rate has significantly reduced. Since adopting the AI system, the misdiagnosis rate has dropped from 9.7% to 0.7% among emergency physicians, 11.3% to 1.58% among resident physicians and 6% to 0.5% among specialist physicians. The model has performed comparably to radiologists and certain orthopedic specialists in terms of quantitative indicators such as sensitivity and specificity.
The smart imaging model for the diagnosis of pelvis and hip injuries is Ping An’s latest achievement in smart imaging technology. Ping An’s smart imaging technology covers nine major systems of human body — the motor, digestive, respiratory, urinary, reproductive, endocrine, immune, nervous and cardiovascular systems. It supports various equipment including computed tomography (CT,) X-ray, ultrasound and fundus optical coherence tomography (OCT).
Sander de Vos Is Appointed Chief Business Officer of IME Medical
April 1, 2021
Sander de Vos will be responsible for the worldwide roll-out of the company’s medical electrospinning strategy, based on IME’s ground-breaking MediSpin™XL industrial production platform.
Judith Heikoop, CEO of IME Medical Electrospinning said, “We at IME are thrilled to welcome Sander to our fast-growing team of professionals. Sander clearly brings a wealth of well-needed life science experience into the company, that will certainly be of key-value to the further development of our electrospun medical device franchises. Our aim is to become the first partner of choice worldwide for the development of a novel, groundbreaking class of medical devices and pharma products based on nanofibers. Our ever-growing portfolio of customers and partners includes the Medtech and Pharma industry, universities, hospitals, and medical institutes.”
Sander de Vos (46) is an accomplished executive with more than 15 years of leadership experience across healthcare and biotech commercial and business development positions. Prior to joining IME, Sander worked at Mimetas, an innovative Dutch start-up company providing novel human cell biology models for improved therapies, where he played a key role in expanding the collaborations with its pharma and biotech partners.
In previous roles, Sander led the commercial team of Isogen Life Science and acquired experience as an entrepreneur growing a private business. His commercial career started at Westburg Life Sciences and for more than 10 years he shaped and directed the sales strategy and commercial development of part of their life science business.
Sander has a background in molecular biology, co-developed a molecular diagnostic test for simultaneous detection of tick-borne pathogens, and contributed to the development of a vaccine against ticks at the Faculty of Veterinary Medicine of the Utrecht University.
Sander de Vos, Chief Business Officer of IME Medical Electrospinning, said: “With the potential of becoming the global leader in large-scale production of best-in-class nanofiber based medical devices and drug delivery solutions, I’m proud, gratified and delighted to become a member of the IME management team. The company’s technology enables faster and better recovery of tissues and body structures, and therefore IME is uniquely positioned to make a meaningful difference in the lives of patients.”
Dipti Itchhaporia, MD, FACC: New American College of Cardiology President
April 1, 2021
Dipti Itchhaporia, MD, FACC, today begins her term as president of the American College of Cardiology.
During her one-year presidency, she will lead the over 54,000-member global organization in its mission to transform cardiovascular care and improve heart health.
“From the moment I became a Fellow of the ACC, I’ve been excited about being a part of this community and contributing to advancing the field of cardiology and the patients we serve,” Itchhaporia said. “I’m looking forward to connecting the cardiovascular community over the next year, as we emerge from a mostly virtual world, to make strides in our strategic priorities and improve the lives of heart disease patients. We must be prepared as a profession to embrace and move to center stage our solutions and vision of digital transformation and health equity.”
Itchhaporia is an interventional cardiologist who is the Eric and Sheila Samson Endowed Chair in Cardiovascular Health, director of disease management for Hoag’s Jeffrey M. Carlton Heart and Vascular Institute in Newport Beach, California, and associate professor of medicine at the University of California, Irvine. She has been a leader in the College for over 20 years, previously holding positions both nationally and in the ACC California Chapter.
Most recently, Itchhaporia held the position of ACC vice president. She previously served as a member of the ACC’s Board of Trustees and the Board of Governors, secretary of the ACC as chair of the Board of Governors, and president of the ACC California Chapter. She has also served on multiple ACC committees and helped to advance the College’s education, science and innovation efforts, including as a member of the ACC Lifelong Learning Oversight Committee, Science and Quality Committee, Governance Committee, Practice Administrator Workgroup and as an advisor for the ACC’s Innovation Program.
Itchhaporia’s professional interests include quality measurement and improvement in cardiovascular disease, focusing on emerging risk factors and medical and lifestyle interventions to prevent coronary heart disease. She is also extensively involved in advancing technology and innovations that will advance the digital transformation of cardiovascular medicine to ultimately improve the lives of patients and clinicians, while helping to achieve health equity.
Itchhaporia’s professional passions have led to leadership roles in advancing the ACC’s strategic priorities, including serving as chair of the ACC Board of Trustees Health Equity Task Force, which addresses issues of health disparities, the social determinants of health and improving access to care for underserved patients. Further work toward health equity will be at the forefront of her presidential year.
“Health equity has been a priority for the College for a long time and for the first time we are feeling like this could be actualized,” Itchhaporia said. “In cardiology we need to have the mindset to prioritize health equity issues, and I’m excited that this is in our reach.”
She received her medical degree from St. Louis University School of Medicine and completed her residency in internal medicine at Stanford University Medical Center. She then joined the general medicine faculty at the University of California, San Francisco (UCSF), ultimately pursuing a cardiology fellowship at Georgetown University and an interventional cardiology fellowship at Stanford University.
Other ACC officers for 2021-2022 are Vice President Edward T. A. Fry, MD, FACC; Board of Governors Chair Joseph Marine, MD, FACC; and Treasurer Christopher M. Kramer, MD, FACC.
Dota 2 Patch 7.29 Will Reveal a New Hero
Pokemon GO announces details for Rivals Week
Valorant Redeem Codes: How to redeem?
MicroStrategy kauft weitere 253 BTC für 15 Millionen US-Dollar
Reports suggest G2 Esports is reviewing its Valorant roster
How to watch the TFT Fates Championship
Ludwig passes 200,000 Twitch subscribers, closes in on Ninja’s record
Best Warzone guns: the weapons you need to use in Black Ops Cold War Season 2
W33 Removed From Team Nigma’s Active Roster
Playa del Carmen: Krypto-Hotspot mit HODLversity
“Lost control,” TM Sentinel issues apology; seeks forgiveness for ‘disgraceful’ comments
Hexagrams and Wolf No Longer Casting the Overwatch League 2021
Tournament platform Epulze secures £4.7m investment
Leading SME finance provider Capify breaking new ground with the launch of their exclusive solution for finance brokers
These are the teams participating in the F1 Pro Series 2021
Unternehmen gründen Crypto Council: Fidelity und Coinbase mit dabei
Standard Chartered turbocharges digital payments proposition with investment and the merger of CurrencyFair with Assembly Payments
Code S RO16: Bunny & Hurricane advance, TY & DRG eliminated
Canceled Black Ops Cold War Battle Royale Map Potentially Leaks
The five most shocking roster moves in CSGO history
Blockchain1 week ago
Bitcoin Cash Price Prediction: BCH/USD Price Turns Bearish; Can the $540 Support Hold?
Blockchain1 week ago
How Chainlink will help secure Polkadot’s environment
Esports6 days ago
GeneRaL is replaced by RAMZES666 on Na’Vi
Blockchain1 week ago
Blockchain-based renewable energy marketplaces gain traction in 2021
Cleantech1 week ago
Volkswagen’s European Factories Up To 95% Powered By Renewables
Aviation1 week ago
World2Fly gears up for July launch with roll-out of Airbus A350-900
PR Newswire1 week ago
Stärkung von Frauen in einer aufstrebenden Branche
Blockchain7 days ago
Mark Cuban Thinks Dogecoin ($DOGE) Could Get to $1, but Could It Get to $10?
Blockchain7 days ago
Hardware Hacker Modifies Old School Game Boy To Mine Bitcoin
Esports1 week ago
PUBG releases limited-time 2D pixel shooter POBG where you get to fight against giant chickens for April Fool’s Day
Coinpedia1 week ago
BitTorrent Token Price Analysis – BTT Poised to Hit $1 In April?
Esports6 days ago
Amouranth becomes Twitch’s top female streamer, beats Pokimane